Related Experiment Video
Updated: Jul 9, 2026

06:48
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Utilizing the tumor-node-metastasis staging for prostate cancer: the sixth edition, 2002
1Vanderbilt University Medical Center, Nashville, TN, USA.
CA: a Cancer Journal for Clinicians
|December 22, 2007
Summary
The Sixth Edition of the tumor-node-metastasis staging system for prostate cancer offers improved clinical evaluation and research capabilities. Ongoing refinements aim to enhance accuracy and incorporate new evidence for better prostate cancer staging.
Area of Science:
- Oncology
- Urology
Background:
- Accurate staging is crucial for prostate cancer patient management and population-level trend analysis.
- The tumor-node-metastasis (TNM) staging system is fundamental in oncology.
- Prostate cancer staging impacts treatment decisions and prognosis.
Purpose of the Study:
- To introduce the modifications in the Sixth Edition of the TNM staging system for prostate cancer.
- To enhance the cohesiveness and uniformity of patient evaluation in prostate cancer.
- To facilitate meaningful clinical research in prostate cancer.
Main Methods:
- The study focuses on the structural and criteria-based changes within the Sixth Edition of the TNM staging system.
- Analysis of modifications aimed at improving standardization of prostate cancer staging.
- Review of the system's potential to aid future clinical research.
Main Results:
- The Sixth Edition incorporates several modifications to refine prostate cancer staging.
- These changes aim to improve the consistency of patient evaluation.
- The revised system is designed to support more robust clinical research.
Conclusions:
- The Sixth Edition of the TNM staging system provides an updated framework for prostate cancer staging.
- Continuous evaluation and incorporation of evidence-based factors are expected for future refinements.
- The system aims to improve both clinical practice and research in prostate cancer.
